THN Global FAQs

Question 1

How does THN Global accelerate drug discovery?

Accepted Answer

It leverages AI to provide deep insights into patent landscapes, assess drug development pipeline feasibility, map regulatory pathways, offer strategic IP recommendations, and deliver in-depth market intelligence, thereby reducing R&D risks and timelines.

Question 2

Does THN Global provide regulatory guidance for drug approval?

Accepted Answer

Yes, THN Global offers detailed Regulatory Pathway Mapping for both FDA (e.g., 505(b)(1), 351(a)) and EMA, outlining required studies, projected timelines, fee schedules, and eligibility for accelerated pathways.

Question 3

Who can benefit from using THN Global?

Accepted Answer

Pharmaceutical and biotech companies, R&D teams, intellectual property departments, and business development units can benefit from THN Global's tools to optimize their drug development processes, reduce costs, and accelerate market entry.

Question 4

What key features does THN Global offer?

Accepted Answer

Key features include Comprehensive Patent Landscape Analysis, AI-Driven Drug Discovery Assessment and Feasibility Scoring, Strategic Intellectual Property Development, Detailed Regulatory Pathway Mapping (FDA/EMA), and In-depth Pharmaceutical Market Intelligence.

Question 5

What is THN Global?

Accepted Answer

THN Global is an AI-powered Model Context Protocol (MCP) server designed for pharmaceutical and biotech companies. It accelerates drug discovery by providing comprehensive patent analysis, strategic intellectual property development, regulatory guidance, and market intelligence.

THN Global

THN Global

主要功能

使用案例

主要功能

使用案例